Cancer Vaccine
Electrofusion process can increase immunogenicity of human cells
Published in Vaccine Weekly, August 31st, 2005
According to recent research from New Zealand, "The cellular products obtained following electrofusion (EF) of dendritic cells (DC) and tumor cells have shown promise as cancer vaccines. The immunogenicity of these preparations has been attributed to the presence of small numbers of DC-tumor hybrids and the contribution of the non-hybrid tumor cells present has received little attention. In this report, we investigated the effect of the EF process on the immunogenicity of allogeneic human cells, in particular the colorectal cell line, SW620."
"EF conditions were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-08-31)
More Articles from Vaccine Weekly
- Ebola Vaccine
Live vaccine protects primates against Ebola and Marburg viruses - Herpes Vaccine
Plasmid-encoded IL-15 protects against herpes virus - Neurocysticercosis Vaccine
Vaccination of pigs controls human neurocysticercosis - Tuberculosis Vaccine
Multicomponent antituberculous vaccine developed - Adenovirus Vector
Capsid modifications enable flexible targeting of adenovirus vectors - Adverse Drug Reaction
Epidemiology study reports new info on hypersensitivity reactions to Abacavir - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
